The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

Mon, 15th Nov 2021 14:15

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Halma PLC - Amersham, England-based safety equipment company - Names Sharmila Nebhrajani as an independent non-executive director, effective from December 1. Nebhrajani will also be a member of Halma's audit, remuneration & nomination committees. She is currently a non-executive director at ITV PLC and Severn Trent PLC, and chair of the National Institute for Health & Care Excellence.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company - Reports the appointment of three new members to its board. Anders Harfstrand joins as non-executive chair, while Deborah Jorn and Jean-Michel Cossery join as non-executive directors, respectively, all with immediate effect. Following the appointment of Harfstrand as non-executive chair, Sam Williams, who has held the role of interim chair since March 2020, will resume his role as a non-executive director and board representative of IP Group PLC.

----------

Angle PLC - Guilford, England-based liquid biopsy company - Appoints Todd Druley to the newly created role of chief medical officer, based in the US. The company says Druley brings highly relevant clinical and business expertise to the planning, development and commercialisation of Angle's diagnostics offerings through its clinical laboratories, regulatory filings and pharma services. Druley held the position of chief medical officer at ArcherDX Inc, a genomic analysis company, before it was acquired by Invitae Corp.

----------

Surgical Innovations Group PLC - Leeds-based medical instrument manufacturing company - Promotes Charmaine Day as chief financial officer with immediate effect. She joined Surgical Innovations in 2012 as financial controller, beginning her career in finance for Eville & Jones Ltd and later as management accountant at Ellis Fairbank PLC. In addition, the company says it considers appropriate board structure to fulfill the future strategic and governance needs of the business. The outcome of this review concludes that the optimal structure is a board of five directors comprising three non-executive directors and two executive directors. As a result, two of the current directors, Alistair Taylor and Adam Power, have indicated their intention to step down from the board with effect from the end of 2021.

----------

Induction Healthcare Group PLC - London-based hospital IT systems provider - Appoints Guy Mitchell as chief financial officer, with immediate effect. He has spent the last ten years specialising in high growth, private equity and venture capital backed software/technology companies, typically businesses with software-as-a-service models and with a global reach and customer base.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Oct 2021 19:51

TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact

TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact

Read more
14 Sep 2021 17:46

TRADING UPDATES: Strong annual results from Springfield, Fiske

TRADING UPDATES: Strong annual results from Springfield, Fiske

Read more
13 Sep 2021 20:23

IN BRIEF: Diurnal's Efmody adrenal treatment launches in UK

IN BRIEF: Diurnal's Efmody adrenal treatment launches in UK

Read more
7 Sep 2021 16:25

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Sep 2021 19:34

TRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition

TRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition

Read more
28 Jul 2021 18:07

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident

Read more
12 Jul 2021 10:10

Diurnal agrees special protocol with FDA for Chronocort study

(Sharecast News) - Specialty pharmaceutical company Diurnal announced on Monday that the US Food and Drug Administration (FDA) has agreed a special protocol assessment (SPA) for 'Chronocort', or modified-release hydrocortisone, for the design, endpoints and statistical analysis approach of a pivotal study of the product, for the treatment for congenital adrenal hyperplasia (CAH).

Read more
2 Jul 2021 10:02

Diurnal gets UK approval for 'Efmody' treatment

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Friday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for 'Efmody', or hydrocortisone modified-release hard capsules, as treatment for adult and adolescent patients with the rare congenital adrenal hyperplasia (CAH) condition.

Read more
2 Jul 2021 10:01

Diurnal gets UK approval for Efmody drug following EU authorisation

Diurnal gets UK approval for Efmody drug following EU authorisation

Read more
29 Jun 2021 17:10

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

TRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan

Read more
1 Jun 2021 20:24

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets

Read more
28 May 2021 19:41

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

TRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend

Read more
12 May 2021 15:30

IN BRIEF: Diurnal extends Citrine licensing deal for Efmody in China

IN BRIEF: Diurnal extends Citrine licensing deal for Efmody in China

Read more
23 Apr 2021 12:56

IN BRIEF: Diurnal gets another patent for adrenal insufficiency asset

IN BRIEF: Diurnal gets another patent for adrenal insufficiency asset

Read more
23 Apr 2021 10:31

Diurnal granted European patent for Alkindi

(Sharecast News) - Hormonal disease-focussed speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.